Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa
- PMID: 3101525
- DOI: 10.4269/ajtmh.1987.36.120
Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa
Abstract
Following the diagnosis in 1981 of the first case of Crimean-Congo hemorrhagic fever (CCHF) in South Africa, an antibody survey was undertaken on cattle sera to determine the distribution of the virus and specific diagnostic tests were routinely applied to specimens from suspected cases of hemorrhagic fever to establish the medical significance of its presence. Antibody to CCHF virus was demonstrated by reversed passive hemagglutination-inhibition technique in 2,460/8,667 (28%) cattle sera and in 140/180 herds tested in South Africa, as well as in 347/763 (45%) cattle sera and in 32/34 (94%) herds tested in Zimbabwe. The antibody was found in all major cattle farming areas, but was of low prevalence along the southern coast where 2 of the 3 species of Hyalomma tick which occur in South Africa are absent. From February 1981 to January 1986, inclusive, 29 indigenous cases of CCHF were diagnosed in 16 outbreaks which arose in various locations throughout South Africa. A further 2 imported cases of CCHF arose in Zaire and Tanzania. The clinical features of infection conformed to the classical descriptions of CCHF in the Soviet Union. The fatal outcome in 11/31 cases indicates that the African disease is no less severe than that which occurs in Eurasia. It is inferred that the virus is widespread in all countries in Africa and Eurasia which lie within the limits of world distribution of ticks of the genus Hyalomma.
Similar articles
-
Antibody to Crimean-Congo hemorrhagic fever virus in wild mammals from southern Africa.Am J Trop Med Hyg. 1987 Jan;36(1):133-42. doi: 10.4269/ajtmh.1987.36.133. Am J Trop Med Hyg. 1987. PMID: 3101526
-
Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.Enferm Infecc Microbiol Clin. 2017 Jun-Jul;35(6):344-347. doi: 10.1016/j.eimc.2017.01.009. Epub 2017 Mar 11. Enferm Infecc Microbiol Clin. 2017. PMID: 28291670 English, Spanish.
-
Crimean-Congo hemorrhagic fever.Antiviral Res. 2004 Dec;64(3):145-60. doi: 10.1016/j.antiviral.2004.08.001. Antiviral Res. 2004. PMID: 15550268 Review.
-
Distribution of Crimean-Congo hemorrhagic fever viral antibody in Senegal: environmental and vectorial correlates.Am J Trop Med Hyg. 1990 Nov;43(5):557-66. doi: 10.4269/ajtmh.1990.43.557. Am J Trop Med Hyg. 1990. PMID: 2122750
-
Crimean-Congo hemorrhagic fever in Tajikistan.Vector Borne Zoonotic Dis. 2012 Sep;12(9):722-6. doi: 10.1089/vbz.2011.0769. Epub 2012 Jan 4. Vector Borne Zoonotic Dis. 2012. PMID: 22217164 Review.
Cited by
-
Genetic characterization of the M RNA segment of Crimean Congo hemorrhagic fever virus strains, China.Emerg Infect Dis. 2002 Jan;8(1):50-3. doi: 10.3201/eid0801.010087. Emerg Infect Dis. 2002. PMID: 11749748 Free PMC article.
-
Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers.Emerg Infect Dis. 2018 Sep;24(9):1642-1648. doi: 10.3201/eid2409.171709. Emerg Infect Dis. 2018. PMID: 30124196 Free PMC article.
-
Seroprevalence and Risk Factors of Crimean-Congo Hemorrhagic Fever in Cattle of Smallholder Farmers in Central Malawi.Pathogens. 2021 Dec 10;10(12):1613. doi: 10.3390/pathogens10121613. Pathogens. 2021. PMID: 34959568 Free PMC article.
-
A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model.PLoS One. 2014 Mar 12;9(3):e91516. doi: 10.1371/journal.pone.0091516. eCollection 2014. PLoS One. 2014. PMID: 24621656 Free PMC article.
-
Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein Augments mRNA Translation.J Virol. 2017 Jul 12;91(15):e00636-17. doi: 10.1128/JVI.00636-17. Print 2017 Aug 1. J Virol. 2017. PMID: 28515298 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources